BioNTech（纳斯达克：BNTX）报告2024年第四季度每股收益€1.08，高于分析师普遍预期的€0.38，超出预期184.21%。与去年同期每股收益€1.88相比下降了42.55%。公司报告季度销售额€11.9亿，高于分析师共识的€10.9亿，超出预期9.04%。与去年同期的销售额€14.8亿相比下降了19.54%。

以上内容来自Benzinga Earnings专栏，原文如下：

BioNTech (NASDAQ:BNTX) reported quarterly earnings of $1.08 per share which beat the analyst consensus estimate of $0.38 by 184.21 percent. This is a 42.55 percent decrease over earnings of $1.88 per share from the same period last year. The company reported quarterly sales of $1.19 billion which beat the analyst consensus estimate of $1.09 billion by 9.04 percent. This is a 19.54 percent decrease over sales of $1.48 billion the same period last year.